Valproic acid Completed Phase 3 Trials for Bipolar Disorder (BD) Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00194116Double-blind, Placebo-Controlled Divalproex Sodium ER in Bipolar I or Bipolar II Depression
NCT02456454Controlled Trial of Valproate Versus Risperidone in Young Children With Bipolar Disorder
NCT00194129Lithium and Divalproex for the Treatment of Comorbid Rapid Cycling Bipolar Disorder and Substance Abuse Disorder
NCT00060905An Inpatient Study of the Effectiveness and Safety of Depakote ER in the Treatment of Mania/Bipolar Disorder
NCT00057681Study of Outcome and Safety of Lithium, Divalproex and Risperidone for Mania in Children and Adolescents
NCT00067262An Outpatient Study of the Effectiveness and Safety of Depakote ER in the Treatment of Mania/Bipolar Disorder in Children and Adolescents
NCT00176202Risperidone and Divalproex Sodium With MRI Assessment in Pediatric Bipolar
NCT00221403Placebo Controlled Trial of Valproate and Risperidone in Young Children With Bipolar Disorders
NCT00254774Efficacy and Safety of Quetiapine Compared With Valproate in the Treatment of Patients With Bipolar Disorder and Rapid Cycling
NCT01188265Add-on Dextromethorphan in Bipolar Disorders